12-49029232-C-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_003482.4(KMT2D):c.14080G>C(p.Glu4694Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000115 in 1,610,704 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
 Genomes: 𝑓 0.000085   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.00012   (  1   hom.  ) 
Consequence
 KMT2D
NM_003482.4 missense
NM_003482.4 missense
Scores
 2
 6
 10
Clinical Significance
Conservation
 PhyloP100:  4.97  
Publications
2 publications found 
Genes affected
 KMT2D  (HGNC:7133):  (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010] 
KMT2D Gene-Disease associations (from GenCC):
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014107972). 
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0000854 (13/152208) while in subpopulation AMR AF = 0.000851 (13/15282). AF 95% confidence interval is 0.000503. There are 0 homozygotes in GnomAd4. There are 7 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.  Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 13 AD gene. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000854  AC: 13AN: 152208Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
13
AN: 
152208
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000586  AC: 146AN: 248970 AF XY:  0.000481   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
146
AN: 
248970
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000118  AC: 172AN: 1458496Hom.:  1  Cov.: 32 AF XY:  0.000105  AC XY: 76AN XY: 724782 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
172
AN: 
1458496
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
76
AN XY: 
724782
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33418
American (AMR) 
 AF: 
AC: 
171
AN: 
44664
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26092
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39580
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86210
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53378
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5764
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1109200
Other (OTH) 
 AF: 
AC: 
1
AN: 
60190
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.496 
Heterozygous variant carriers
 0 
 9 
 18 
 28 
 37 
 46 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000854  AC: 13AN: 152208Hom.:  0  Cov.: 32 AF XY:  0.0000941  AC XY: 7AN XY: 74364 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
13
AN: 
152208
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
7
AN XY: 
74364
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41454
American (AMR) 
 AF: 
AC: 
13
AN: 
15282
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5194
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4836
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68032
Other (OTH) 
 AF: 
AC: 
0
AN: 
2090
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.487 
Heterozygous variant carriers
 0 
 1 
 3 
 4 
 6 
 7 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ExAC 
 AF: 
AC: 
52
ClinVar
Significance: Conflicting classifications of pathogenicity 
Submissions summary: Pathogenic:1Benign:3Other:1 
Revision: criteria provided, conflicting classifications
LINK: link 
Submissions by phenotype
not specified    Benign:1Other:1 
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population
- -
Mar 07, 2014
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Kabuki syndrome 1    Pathogenic:1 
Nov 01, 2016
Center for Human Genetics, Inc, Center for Human Genetics, Inc
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Kabuki syndrome    Benign:1 
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Apr 20, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Benign 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 DEOGEN2 
 Benign 
T 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Benign 
T 
 M_CAP 
 Uncertain 
D 
 MetaRNN 
 Benign 
T 
 MetaSVM 
 Uncertain 
D 
 MutationAssessor 
 Benign 
L 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Benign 
N 
 REVEL 
 Uncertain 
 Sift 
 Benign 
T 
 Polyphen 
D 
 Vest4 
 MVP 
 MPC 
 ClinPred 
T 
 GERP RS 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.